Sponsors (2)
The resolution raises important awareness and data-driven responses to the deadly rise of fentanyl—likely improving prevention, naloxone access, and law-enforcement/public-health coordination—but risks steering policy and funding toward enforcement and alarm-driven, punitive responses instead of expanded treatment and harm-reduction.
Young adults (ages 18–45) are more likely to receive targeted prevention and treatment as the resolution recognizes fentanyl as a leading cause of death for that age group.
Patients at risk of overdose and local emergency responders could see wider availability and use of naloxone and drug-testing resources because the resolution highlights fentanyl's extreme potency and tiny lethal dose.
Law enforcement and public-health agencies may improve coordination on interdiction and prevention due to increased emphasis on overdose data and chemical sourcing.
Taxpayers and local communities could see resources shifted toward enforcement (seizures, interdiction) rather than treatment and harm-reduction, reducing access to evidence-based care for people who use drugs.
The general public may be exposed to heightened fear and support for punitive policies because of alarming framings (e.g., seized doses described as 'enough to kill every individual'), which can undermine public-health approaches and civil liberties.
Border communities and taxpayers could face higher enforcement costs or trade disruptions if attributing primary production to foreign sources increases pressure for tougher border measures.
Based on analysis of 2 sections of legislative text.
Makes congressional findings documenting the scale, causes, and risks of the U.S. fentanyl-driven overdose crisis as of 2024.
Official title: Expressing support for the designation of February 23, 2025, to March 1, 2025, as "National Fentanyl Awareness Week" and raising awareness of the negative impacts of fentanyl in the United States.
Introduced February 25, 2025 by Richard Lynn Scott · Last progress February 25, 2025
Declares findings about the U.S. opioid/fentanyl overdose crisis as of 2024, summarizing recent overdose deaths, fentanyl potency and lethal dose, large law-enforcement seizures, trends in counterfeit pills and drug contamination, demographic shifts in overdose rates, and sources of illicit fentanyl production and precursor chemicals. The text is a factual preamble meant to document the scale, harms, and supply-chain drivers of the fentanyl crisis for policymakers and the public.